BrainCells garners $17.7M in round one

San Diego-based BrainCells has raised $17.7 million in its first round of venture capital. Technology Partners and seed investors Oxford Bioscience Partners and Bay City Capital led the round. BrainCells was founded by Fred H. Gage and Harry Hixson in December 2003 to capitalize on Dr. Gage's discoveries that humans generate new nerve cells throughout life and that this endogenous process -- neurogenesis -- can be manipulated using known small molecule therapeutics.

- read this press release for more

PLUS: Cambridge, Massachusetts-based Peptimmune has closed a $20.4 million third round. Release

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.